Tech Center 1600 • Art Units: 1637 1681 1683
This examiner grants 71% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18282467 | METHODS AND MATERIALS FOR IDENTIFYING MYELOMA STAGE AND DRUG SENSITIVITY AND TREATING MYELOMA | Non-Final OA | Mayo Foundation for Medical Education and Research |
| 18710722 | ENZYME-FREE ISOTHERMAL EXPONENTIAL AMPLIFICATION | Non-Final OA | Dana-Farber Cancer Institute, Inc. |
| 18468971 | Methods for Microbial Identification in Clinical Specimens by Differential Ribosomal RNA Probe Hybridization | Non-Final OA | The Regents of the University of California |
| 18055024 | Multiplex End-Tagging Amplification of Nucleic Acids | Non-Final OA | President and Fellows of Harvard College |
| 18262519 | QUANTIFICATION OF CELLULAR PROTEINS USING BARCODED BINDING MOIETIES | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18441809 | METHODS FOR SEQUENCING BIOPOLYMERS | Non-Final OA | Arizona Board of Regents on behalf of Arizona State University |
| 18282138 | PREECLAMPSIA DIAGNOSIS | Final Rejection | Katholieke Universiteit Leuven |
| 18418143 | ASSAY FOR DETECTING CLOSELY-RELATED SEROTYPES OF HUMAN PAPILLOMAVIRUS (HPV) | Non-Final OA | Becton, Dickinson and Company |
| 18760831 | Anodized Metal Oxide Substrates Supporting Solid Support Feature Arrays for Patterned Flowcells | Non-Final OA | Illumina, Inc. |
| 17618836 | METHODS FOR SEQUENCING POLYNUCLEOTIDES | Final Rejection | Illumina, Inc. |
| 18498328 | METHODS OF MRNA POLY(A) TAIL LENGTH AND HETEROGENEITY ANALYSIS | Final Rejection | Waters Technologies Corporation |
| 18362238 | Human Fractional Abundance Assays | Final Rejection | IDEXX Laboratories, Inc. |
| 17686083 | METHODS, COMPOSITIONS AND KITS FOR SMALL RNA CAPTURE, DETECTION AND QUANTIFICATION | Non-Final OA | LIFE TECHNOLOGIES CORPORATION |
| 17792812 | METHOD FOR SURVEYING ECOSYSTEM IN WATER ENVIRONMENT BY USING ENVIRONMENTAL RNA | Non-Final OA | Kao Corporation |
| 18055822 | METHODS AND COMPOSITIONS FOR DETERMINING, AND FOR MINIMIZING, THE LIKELIHOOD OF DEVELOPMENT OF ALLERGY IN INFANTS | Non-Final OA | MURDOCH CHILDREN'S RESEARCH INSTITUTE |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy